Neuropsychiatric disorders such as schizophrenia, bipolar disorder, and major depressive disorder are serious, debilitating, and clinically complex disorders that often pose a considerable challenge to clinicians. While practice guidelines may assist clinicians in management, clinical trial data is often rapidly emerging to identify evidence-based strategies to optimize clinical management.
Given the significant clinical and quality of life impact of neuropsychiatric disorders, the identification and implementation of safe, effective management strategies is paramount. Our Neuropsychiatric Hub is designed to provide clinicians with the latest practice guidelines, diagnostic strategies and tools, and scientific updates on current and emerging therapies to optimize management of neuropsychiatric disorders.
In this CME Outfitters podcast episode, expert faculty will discuss cultural and systemic challenges faced by ethnic/racially diverse patients, and empower health care professionals with education, tools, and resources to address these challenges and provide more equitable mental health care for all.
Join expert faculty in this live CMEO webcast as they discuss topics including early diagnosis, patient/caregiver QoL, team-based care, the role of pharmaceutical cannabinoid (CBD) in treatment, and regulatory guidelines.
In this educational webcast, expert faculty will discuss treatment needs of adult patients with SMA and the unique challenges and experiences of those patients transitioning from pediatric to adult care.
The first installment of this 4-part CME Outfitters series on ADHD will feature a discussion by Drs. Ann Childress and Thomas E. Brown on the extensive burden and impact of ADHD in children and adults. Additionally, the activity will include the use of a 3-D model highlighting the various systems and domains impacted.
Guided by the perspectives of racially and ethnically diverse individuals living with schizophrenia, the final installment in this CME Outfitters Snack series will provide clinicians with tools and strategies to address racial disparities in the diagnosis and management of this disease.